Quality of life in patients with B-cell lymphoma during maintenance therapy with the Anti-CD20 antibody rituximab

被引：0
|
作者：
Witzens-Harig, Mathias [1 ]
Heiss, Christiane [2 ]
Benner, Axel [2 ]
Hensel, Manfred [1 ]
Neben, Kai [1 ]
Dreger, Peter [1 ]
Kraemer, Alwin [1 ]
Ho, Anthony D. [1 ]
机构：
[1] Univ Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4471.4471
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4471
引用
收藏
页码：189B / 189B
页数：1
相关论文
共 50 条
  • [21] Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
    Kazutaka Takagi
    Akira Yoshida
    Hiromichi Iwasaki
    Hitoshi Inoue
    Takanori Ueda
    Annals of Hematology, 2005, 84 : 548 - 550
  • [22] Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
    Takagi, K
    Yoshida, A
    Iwasaki, H
    Inoue, H
    Ueda, T
    ANNALS OF HEMATOLOGY, 2005, 84 (08) : 548 - 550
  • [23] Anti-CD20 monoclonal antibody (rituximab) for therapy of T-cell/histiocyte-rich large B-cell non-Hodgkin lymphoma
    Park, ES
    Lim, JJ
    Kang, HJ
    Shin, HY
    Ahn, HS
    BLOOD, 2005, 106 (11) : 282B - 282B
  • [24] The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma
    Flavell, DJ
    Warnes, SL
    Bryson, CJ
    Field, SA
    Noss, AL
    Packham, G
    Flavell, SU
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 134 (02) : 157 - 170
  • [25] RADIOIMMUNOTHERAPY OF B-CELL LYMPHOMA WITH [I-131] ANTI-B1 (ANTI-CD20) ANTIBODY
    KAMINSKI, MS
    ZASADNY, KR
    FRANCIS, IR
    MILIK, AW
    ROSS, CW
    MOON, SD
    CRAWFORD, SM
    BURGESS, JM
    PETRY, NA
    BUTCHKO, GM
    GLENN, SD
    WAHL, RL
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (07): : 459 - 465
  • [26] RADIOIMMUNOTHERAPY OF REFRACTORY B-CELL LYMPHOMA WITH 131-I-ANTI-B1 (ANTI-CD20) ANTIBODY
    KAMINSKI, MS
    FENNER, M
    ZASADNY, KR
    MILIK, AW
    ROSS, CW
    FRANCIS, IR
    BURGESS, J
    ESTES, J
    CRAWFORD, S
    HODUL, P
    COOK, R
    REGAN, D
    PETRY, N
    GLENN, S
    BUTCHKO, G
    WAHL, RL
    CLINICAL RESEARCH, 1994, 42 (03): : A405 - A405
  • [27] Anti-CD20 (rituximab) in follicular lymphoma
    McLaughlin, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S51 - S51
  • [28] B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
    Shaw, T
    Quan, J
    Totoritis, MC
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 55 - 59
  • [29] Characterization of a humanized anti-CD20 antibody with potent antitumor activity against B-cell lymphoma
    Wu, Lan
    Wang, Chong
    Zhang, Dapeng
    Zhang, Xunming
    Qian, Weizhu
    Zhao, Lei
    Wang, Hao
    Li, Bohua
    Guo, Yajun
    CANCER LETTERS, 2010, 292 (02) : 208 - 214
  • [30] Rituximab (anti-CD20 monoclonal antibody) immunotherapy in patients with B-cell non-Hodgkin's lymphoma:: highly effective treatment of residual disease
    Papajík, T
    Szotkowski, T
    Raida, L
    Hubáek, J
    Faber, E
    Hlusí, A
    Vondráková, J
    Pikalová, Z
    Jedliková, K
    Jarosová, M
    Indrák, K
    LEUKEMIA, 2001, 15 (03) : 510 - 510
12345